CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+4.72%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.93B
AUM Growth
+$2.93B
(+2.5%)
Cap. Flow
-$94.4M
Cap. Flow
% of AUM
-3.22%
Top 10 Holdings %
Top 10 Hldgs %
66.45%
Holding
46
New
7
Increased
9
Reduced
7
Closed
5
Top Buys
| 1 |
Baxter International
BAX
|
$122M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$51.9M |
| 3 |
CONMED
CNMD
|
$33.8M |
| 4 |
GSK
GSK
|
$30.2M |
| 5 |
Universal Health Services
UHS
|
$28.6M |
Top Sells
| 1 |
Align Technology
ALGN
|
$109M |
| 2 |
Sanofi
SNY
|
$81.6M |
| 3 |
Sarepta Therapeutics
SRPT
|
$68.9M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$64.3M |
| 5 |
Qiagen
QGEN
|
$37.4M |
Sector Composition
| 1 | Healthcare | 98.65% |
| 2 | Consumer Staples | 0.67% |
| 3 | Consumer Discretionary | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sanofi
SNY
$121B
| $299M | 9.2% | 5,500,000 -1,500,000 | -21% | -$81.6M |
|
|
2
Universal Health Services
UHS
$11.6B
| $245M | 7.52% | 1,925,000 +225,000 | +13% | +$28.6M |
|
3
Tenet Healthcare
THC
$16.3B
| $229M | 7.04% | 3,850,000 -150,000 | -4% | -$8.91M |
|
|
WBA
4
DELISTED
Walgreens Boots Alliance
WBA
| $225M | 6.91% | 6,500,000 +1,500,000 | +30% | +$51.9M |
|
5
Viatris
VTRS
$12.3B
| $216M | 6.66% | 22,500,000 +2,500,000 | +13% | +$24.1M |
|
|
6
GSK
GSK
$79.9B
| $164M | 5.03% | 4,600,000 +850,000 | +23% | +$30.2M |
|
7
Myriad Genetics
MYGN
$593M
| $163M | 5% | 7,000,000 | – | – |
|
8
Zimmer Biomet
ZBH
$21B
| $162M | 4.97% | 1,250,000 | – | – |
|
9
Select Medical
SEM
$1.61B
| $124M | 3.82% | 4,800,000 | – | – |
|
|
10
Baxter International
BAX
$12.7B
| $122M | 3.74% | +3,000,000 | New | +$122M |
|
11
PTC Therapeutics
PTCT
$3.92B
| $121M | 3.72% | 2,500,000 -250,000 | -9% | -$12.1M |
|
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $103M | 3.18% | 750,000 -500,000 | -40% | -$68.9M |
|
13
Perrigo
PRGO
$3.27B
| $89.7M | 2.76% | 2,500,000 | – | – |
|
14
Dentsply Sirona
XRAY
$2.85B
| $69.3M | 2.13% | 1,765,000 | – | – |
|
15
Ionis Pharmaceuticals
IONS
$6.79B
| $68.8M | 2.12% | 1,925,000 | – | – |
|
16
Brookdale Senior Living
BKD
$1.83B
| $53.1M | 1.63% | 18,000,000 | – | – |
|
|
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $52.1M | 1.6% | 1,400,000 | – | – |
|
18
Quanterix
QTRX
$211M
| $38.6M | 1.19% | 3,425,000 | – | – |
|
|
19
CONMED
CNMD
$1.68B
| $33.8M | 1.04% | +325,000 | New | +$33.8M |
|
20
Exelixis
EXEL
$10.1B
| $30.1M | 0.93% | 1,550,000 +200,000 | +15% | +$3.88M |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $26.6M | 0.82% | 3,000,000 -4,000,000 | -57% | -$35.4M |
|
22
OraSure Technologies
OSUR
$242M
| $25.7M | 0.79% | 4,250,000 | – | – |
|
23
Centene
CNC
$14.3B
| $25.3M | 0.78% | +400,000 | New | +$25.3M |
|
24
Collegium Pharmaceutical
COLL
$1.22B
| $25.2M | 0.77% | 1,050,000 | – | – |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| $24.8M | 0.76% | 600,000 +100,000 | +20% | +$4.13M |
|